Page 9 - Decision Diagnostics Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Decision diagnostics corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Decision Diagnostics Corp Today - Breaking & Trending Today

Decision Diagnostics Corp.: DECN Comments on Recent Legal Filings by Federal Agencies

Decision Diagnostics Corp.: DECN Comments on Recent Legal Filings by Federal Agencies
LOS ANGELES, CA / ACCESSWIRE / December 18, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., as well as the designer and manufacturer of the GenViro! Covid-19 Swift Kit testing kits, hereby confirms two recent legal filings by separate agencies of the Federal government regarding DECN and its CEO Keith Berman concerning its GenViro! Covid-19 testing products.
Keith Berman, the CEO of DECN, was charged yesterday in Los Angeles by the United States Department of Justice with one count of securities fraud and one count of making a false statement to government officials. It is alleged that Mr. Berman made false and misleading statements in connection with DECN s effort to develop, test and obta ....

New York , United States , Los Angeles , Keith Berman , Exchange Commission , Pharma Tech Solutions Inc , United States Department Of Justice , Decision Diagnostics Corp , York Federal Court , Decision Diagnostics , Pharma Tech Solutions , United States Department , United States Securities , New York Federal , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , கேய்ட் பெர்மன் , பரிமாற்றம் தரகு , பார்மா தொழில்நுட்பம் தீர்வுகள் இன்க் , ஒன்றுபட்டது மாநிலங்களில் துறை ஆஃப் நீதி , முடிவு பரிசோதனை கார்ப் , யார்க் கூட்டாட்சியின் நீதிமன்றம் , முடிவு பரிசோதனை , பார்மா தொழில்நுட்பம் தீர்வுகள் , ஒன்றுபட்டது மாநிலங்களில் துறை ,

DECN Comments on Recent Legal Filings by Federal Agencies

DECN Comments on Recent Legal Filings by Federal Agencies
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Los Angeles , Keith Berman , Exchange Commission , Pharma Tech Solutions Inc , United States Department Of Justice , Decision Diagnostics Corp , York Federal Court , Decision Diagnostics , Pharma Tech Solutions , United States Department , United States Securities , New York Federal , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , கேய்ட் பெர்மன் , பரிமாற்றம் தரகு , பார்மா தொழில்நுட்பம் தீர்வுகள் இன்க் , ஒன்றுபட்டது மாநிலங்களில் துறை ஆஃப் நீதி , முடிவு பரிசோதனை கார்ப் , யார்க் கூட்டாட்சியின் நீதிமன்றம் , முடிவு பரிசோதனை , பார்மா தொழில்நுட்பம் தீர்வுகள் , ஒன்றுபட்டது மாநிலங்களில் துறை ,

DECN EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Decision Diagnostics Corp. – DECN

DECN EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Decision Diagnostics Corp. – DECN
businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.

Keith Berman , Phillip Kim , Chinese Company , Decision Diagnostics Corp , Exchange Commission , Securities Class Action Services , Rosen Law Firm , Decision Diagnostics , Law Firm , Class Action Services , கேய்ட் பெர்மன் , பிலிப் கிம் , சீன நிறுவனம் , முடிவு பரிசோதனை கார்ப் , பரிமாற்றம் தரகு , பத்திரங்கள் வர்க்கம் நடவடிக்கை சேவைகள் , ரோஸன் சட்டம் நிறுவனம் , முடிவு பரிசோதனை , சட்டம் நிறுவனம் , வர்க்கம் நடவடிக்கை சேவைகள் ,

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device
Washington, D.C. (Newsfile Corp. - December 18, 2020) - The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics securities on April 23, 2020.
The SEC s complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and mislea ....

New York , United States , District Of Columbia , Stephanie Avakian , Hanel Kim , James Carlson , Keith Berman , Tom Bednar , Jeff Leasure , Carlisle Perkins , Margareta Cain , Kostenloser Wertpapierhandel , David Misler , Lesley Atkins , Coronavirus Steering Committee , Decision Diagnostics Corp , Dc Newsfile Corp , Financial Industry Regulatory Authority , Division Of Enforcement , Us District Court , Microcap Fraud Task , Office Of Market Intelligence , Exchange Commission , Department Of Justice Market Integrity , Decision Diagnostics , Decision Diagnostic ,

SEC Lawsuit Alleges Biotech Firm, CEO Misled Investors About COVID-19 Tests

SEC Lawsuit Alleges Biotech Firm, CEO Misled Investors About COVID-19 Tests
The U.S. Securities and Exchange Commission sued Decision Diagnostics Corp. and its chief executive for allegedly misleading investors by promising the biotechnology company could test for COVID-19 with a finger-prick of blood and provide accurate results in less than one minute.
In a complaint filed on Thursday in Manhattan federal court, the SEC said Chief Executive Keith Berman made materially false statements between March and June about what he claimed was his company’s blood testing kit, and its efforts to obtain Food and Drug Administration approval for its emergency use. ....

New York , United States , Keith Berman , Jonathan Stempel , Exchange Commission , Decision Diagnostics Corp , Drug Administration , Decision Diagnostics , Chief Executive Keith Berman , Decision Diagnostic , Will Dunham , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , கேய்ட் பெர்மன் , ஜொனாதன் ஸ்டெம்பல் , பரிமாற்றம் தரகு , முடிவு பரிசோதனை கார்ப் , முடிவு பரிசோதனை , தலைமை நிர்வாகி கேய்ட் பெர்மன் , முடிவு கண்டறியும் , விருப்பம் டன்ஹாம் ,